Artificial miRNAs targeting CAG repeat expansion in ORFs cause rapid deadenylation and translation inhibition of mutant transcripts.

Cellular and Molecular Life Sciences : CMLS
Adam CiesiolkaAgnieszka Fiszer

Abstract

Polyglutamine (polyQ) diseases are incurable neurological disorders caused by CAG repeat expansion in the open reading frames (ORFs) of specific genes. This type of mutation in the HTT gene is responsible for Huntington's disease (HD). CAG repeat-targeting artificial miRNAs (art-miRNAs) were shown as attractive therapeutic approach for polyQ disorders as they caused allele-selective decrease in the level of mutant proteins. Here, using polyQ disease models, we aimed to demonstrate how miRNA-based gene expression regulation is dependent on target sequence features. We show that the silencing efficiency and selectivity of art-miRNAs is influenced by the localization of the CAG repeat tract within transcript and the specific sequence context. Furthermore, we aimed to reveal the events leading to downregulation of mutant polyQ proteins and found very rapid activation of translational repression and HTT transcript deadenylation. Slicer-activity of AGO2 was dispensable in this process, as determined in AGO2 knockout cells generated with CRISPR-Cas9 technology. We also showed highly allele-selective downregulation of huntingtin in human HD neural progenitors (NPs). Taken together, art-miRNA activity may serve as a model of the coopera...Continue Reading

References

Mar 17, 1999·Neuroscience Letters·N TakahashiS Ishiura
Jul 21, 2004·Molecular Cell·Gunter MeisterThomas Tuschl
Jul 31, 2004·Science·Jidong LiuGregory J Hannon
Apr 1, 2005·Nature Structural & Molecular Biology·Fabiola V RivasLeemor Joshua-Tor
Aug 6, 2005·Science·Ramesh S PillaiWitold Filipowicz
Sep 6, 2005·Science·Catherine L JoplingPeter Sarnow
Oct 11, 2005·Analytical Biochemistry·Mimi C Sammarco, Ed Grabczyk
Jul 4, 2006·Genes & Development·Isabelle Behm-AnsmantElisa Izaurralde
Mar 29, 2007·Nucleic Acids Research·Pål SaetromJohn J Rossi
Jul 7, 2007·Molecular Cell·Andrew GrimsonDavid P Bartel
Mar 28, 2008·RNA·Anja M DuursmaReuven Agami
May 24, 2008·Molecular Cell·Ulf Andersson ØromAnders H Lund
Sep 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Joshua J FormanHilary A Coller
Nov 26, 2008·RNA·Ana EulalioElisa Izaurralde
Feb 3, 2009·Nature Structural & Molecular Biology·Shuo GuMark A Kay
Aug 4, 2009·Molecular Cell·Irina ElchevaVladimir S Spiegelman
Apr 8, 2010·Cell Cycle·Joshua J Forman, Hilary A Coller
Nov 12, 2010·BMC Research Notes·Keiko SuzukiKarl Riabowol
Nov 18, 2010·Molecular Systems Biology·Erik LarssonDebora Marks
Mar 24, 2011·Nucleic Acids Research·Agnieszka FiszerWlodzimierz J Krzyzosiak
Mar 30, 2011·PloS One·Zhuo Fang, Nikolaus Rajewsky
Jun 21, 2011·Genome Research·Michael Schnall-LevinBonnie Berger
Oct 11, 2011·Molecular Cell·Joerg E BraunElisa Izaurralde
Oct 11, 2011·Nature Structural & Molecular Biology·Marina ChekulaevaWitold Filipowicz
Oct 11, 2011·Nature Structural & Molecular Biology·Marc R FabianNahum Sonenberg
Jan 31, 2012·Current Opinion in Genetics & Development·Harry T Orr
Jan 31, 2012·Drug Discovery Today·Masayuki Matsui, David R Corey
Apr 5, 2012·Genes & Development·Dongmei WangRui Yi
Jun 6, 2012·Nature Structural & Molecular Biology·Marc R Fabian, Nahum Sonenberg
Jul 31, 2012·Nucleic Acids Research·Anne DueckGunter Meister
Sep 22, 2012·Nature·Michael J HawrylyczAllan R Jones

❮ Previous
Next ❯

Citations

Feb 10, 2021·International Journal of Molecular Sciences·Lukasz PrzybylAgnieszka Fiszer
Jul 3, 2021·International Journal of Molecular Sciences·Edyta KoscianskaAgnieszka Fiszer
May 20, 2021·Current Opinion in Neurology·Jose Miguel Laffita-MesaPer Svenningsson
Sep 24, 2021·Wiley Interdisciplinary Reviews. RNA·Martyna KordyśZbigniew Warkocki

❮ Previous
Next ❯

Datasets Mentioned

BETA
GM05565

Methods Mentioned

BETA
transfection
smFISH
immunoprecipitation
transfect
PCRs
PCR
Assay
scraping
RNA-seq
antisense oligonucleotide

Clinical Trials Mentioned

NCT03842969

Software Mentioned

GraphPad Prism
ImageJ
StarSearch

Related Concepts

Related Feeds

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.